Ligand Pharmaceuticals LGND
NASDAQ LGND
$302.96 +0.22 (+0.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Cash from Discontinued Operations (2010 - 2013)

Updated

Ligand Pharmaceuticals (LGND) posted Cash from Discontinued Operations of -$642,000 for FY2013, compared with -$900,000 in FY2012.

Analysis

Ligand Pharmaceuticals (LGND) Cash from Discontinued Operations (2010 - 2013) Analysis & Trends

Since FY2009, Ligand Pharmaceuticals has reported Cash from Discontinued Operations for 4 years.

  • The FY2013 figure stands as the highest annual Cash from Discontinued Operations since FY2010.
  • Business Quant data shows LGND's Cash from Discontinued Operations at -$900,000 in FY2012, $240,000 in FY2010 and -$3.16 million in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.87 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Ligand Pharmaceuticals 6.03 Bn 2.50 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 -642,000.00
Dec 31, 2012 -350,000.00
Sep 30, 2012 -350,000.00
Mar 31, 2012 -200,000.00
Dec 31, 2010 -22,000.00
Sep 30, 2010 -1,000.00
API Access

Ligand Pharmaceuticals Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=LGND&period=max&api_key=YOUR_API_KEY